Innovative Pharmaceutical Biotech Limited (0399.HK)
HKD 0.17
(0.0%)
HKD 0.17
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 6.59 Million | 8.07 Million | 11.14 Million | 15.18 Million | 14.58 Million | 18.58 Million |
| Cost of Revenue | 5.75 Million | 7.21 Million | 10.09 Million | 13.78 Million | 12.96 Million | 16.84 Million |
| Gross Profit | 840 Thousand | 858 Thousand | 1.05 Million | 1.4 Million | 1.62 Million | 1.74 Million |
| Operating Expenses | 14.27 Million | 21.56 Million | 25.48 Million | 22.79 Million | 33.97 Million | 28.67 Million |
| Selling, General and Administrative Expenses | 12.91 Million | 17.03 Million | 17.24 Million | 16.91 Million | 22.64 Million | 26.74 Million |
| Research and Development Expenses | 1.42 Million | 4.75 Million | 8.24 Million | 6.09 Million | 11.33 Million | 1.93 Million |
| Other Expenses | - | 1000.00 | 80 Thousand | -212 Thousand | 9000.00 | - |
| Cost and Expenses | 20.02 Million | 28.77 Million | 35.58 Million | 36.57 Million | 46.93 Million | 45.52 Million |
| Operating Income | -13.43 Million | -20.7 Million | -24.35 Million | -21.34 Million | -26.01 Million | -11.61 Million |
| Interest Expense | 218.09 Million | 233.96 Million | 189.95 Million | 191.03 Million | 147.03 Million | 131.69 Million |
| Income Tax Expense | - | -8.97 Million | -260.1 Million | 183.59 Million | 185.1 Million | 116.96 Million |
| Earnings before Tax | 98.7 Million | -254.67 Million | 36.43 Million | -212.15 Million | -222.46 Million | -260.91 Million |
| Net Income | 103.4 Million | -245.69 Million | 296.53 Million | -395.75 Million | -407.56 Million | -260.27 Million |
| Earnings Per Share Basic | -0.01 | -0.17 | 0.20 | -0.27 | -0.28 | -0.18 |
| Earnings Per Share Diluted | -0.01 | -0.17 | 0.17 | -0.27 | -0.28 | -0.18 |
| Weighted Average Shares Outstanding | 1.52 Billion | 1.46 Billion | 1.46 Billion | 1.46 Billion | 1.46 Billion | 1.46 Billion |
| Weighted Average Shares Outstanding (Diluted) | 2.49 Billion | 1.46 Billion | 1.75 Billion | 1.46 Billion | 1.46 Billion | 1.46 Billion |
| Gross Margin | 0.13 | 0.11 | 0.09 | 0.09 | 0.11 | 0.09 |
| EBIT Margin | 48.19 | -2.33 | -1.99 | -1.25 | -1.70 | -0.62 |
| Profit Margin | 15.68 | -30.43 | 26.61 | -26.06 | -27.95 | -14.00 |
| EBITDA | 317.74 Million | -18.82 Million | -22.3 Million | -18.81 Million | -80.49 Million | -129.15 Million |
| Earnings Before Tax Margin | -2.04 | -2.56 | -2.19 | -1.41 | -1.78 | -0.62 |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Revenue | 6.59 Million | 2.86 Million | 1.43 Million | 3.72 Million | 1.86 Million | 8.07 Million |
| Cost of Revenue | 5.75 Million | 2.4 Million | 1.2 Million | 3.34 Million | 1.67 Million | 7.21 Million |
| Gross Profit | 840 Thousand | 460 Thousand | 230 Thousand | 380 Thousand | 190 Thousand | 858 Thousand |
| Operating Expenses | 14.27 Million | 7.74 Million | 3.85 Million | 6.59 Million | 161.83 Million | 21.56 Million |
| Selling, General and Administrative Expenses | - | 6.63 Million | 3.31 Million | 6.28 Million | 3.14 Million | - |
| Research and Development Expenses | - | 1.11 Million | 559 Thousand | 303 Thousand | 151.5 Thousand | - |
| Other Expenses | 1000.00 | - | - | - | - | 1000.00 |
| Cost and Expenses | 20.02 Million | 10.15 Million | 5.05 Million | 9.93 Million | 163.51 Million | 28.77 Million |
| Operating Income | -13.43 Million | -7.28 Million | -3.64 Million | -6.21 Million | -3.1 Million | -20.7 Million |
| Interest Expense | 218.09 Million | 86.61 Million | - | 131.47 Million | - | 233.96 Million |
| Income Tax Expense | -4.69 Million | -3.58 Million | -1.79 Million | -1.11 Million | -555.5 Thousand | -8.97 Million |
| Earnings before Tax | 98.7 Million | -93.87 Million | -46.93 Million | 192.57 Million | 96.28 Million | -254.67 Million |
| Net Income | 103.4 Million | -90.28 Million | -45.14 Million | 193.68 Million | 96.84 Million | -245.69 Million |
| Earnings Per Share Basic | - | -0.06 | -0.03 | 0.13 | 0.07 | - |
| Earnings Per Share Diluted | - | -0.04 | -0.03 | -0.02 | 0.06 | - |
| Weighted Average Shares Outstanding | 1.52 Billion | 1.52 Billion | 1.58 Billion | 1.46 Billion | 1.46 Billion | 1.46 Billion |
| Weighted Average Shares Outstanding (Diluted) | 2.49 Billion | 2.49 Billion | 1.58 Billion | 1.75 Billion | 1.75 Billion | 1.46 Billion |
| Gross Margin | 0.13 | 0.16 | 0.16 | 0.10 | 0.10 | 0.11 |
| EBIT Margin | - | -2.48 | -2.21 | -1.46 | -1.41 | - |
| Profit Margin | 15.68 | -31.50 | -31.50 | 51.97 | 51.97 | -30.43 |
| EBITDA | - | -7.1 Million | -3.17 Million | -5.45 Million | -2.63 Million | - |
| Earnings Before Tax Margin | -2.04 | -2.54 | -2.54 | -1.67 | -1.67 | -2.56 |
7177
7822
AKEL-D
LAM
AOIFF
TCS